FridayNov 30, 2018 11:43 am

QualityStocksNewsBreaks – BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) Developing Targeted, Safe Cancer Treatment Options

BriaCell Therapeutics (OTCQB: BCTXF) (TSX.V: BCT) is a biotechnology company focusing its efforts on immuno-oncology through the development of targeted, safe treatment options for cancer. A recent article discussing the company reads, “Currently, BriaCell Therapeutics has two major programs – Bria-IMT and Bria-OTS. Bria-IMT is currently in the clinic, while Bria-OTS is in the process of development, Williams said. Previous clinical testing of Bria-IMT has returned promising results. In a clinical trial for the treatment of advanced breast cancer, Bria-IMT contributed to tumor shrinkage in multiple sites (in patients with metastases). Through additional patient testing, the original observations were confirmed.”…

Continue Reading

FridayNov 30, 2018 10:58 am

QualityStocksNewsBreaks – Zenergy Brands, Inc. (ZNGY) Employs Modern Approach to Energy Conservation

“Virtual utility” company Zenergy Brands (OTC: ZNGY) utilizes digitalization to consume energy in a more efficient, responsible manner. A recent article discussing the company reads, “A virtual utility like Zenergy can help resolve those difficulties because of its technological solutions, mainly the Zero Cost Program, and its position as an energy provider. The Zero Cost Program allows customers to upgrade their energy gadgets to more efficient, cost-reducing appliances at no additional expense. The program reduces utility consumption by 20-60 percent by furnishing energy conservation, smart controls and efficiency-based products and services to residential, commercial, industrial and municipal end-use customers.” To…

Continue Reading

FridayNov 30, 2018 10:41 am

QualityStocksNewsBreaks – The Flowr Corporation (TSX.V: FLWR) Nominates Three Independent Directors

Canadian Licensed Producer of premium cannabis products The Flowr Corporation (TSX.V: FLWR) today announced its nomination of Karen Basian, Maurice Levesque and Dr. J. André de Barros Teixeira to stand for election to the company’s board of directors at its December 28, 2018 shareholder meeting. Basian brings over 25 years of experience in the consumer products, financial services and technology sectors. Levesque has 30 years of experience in the Canadian financial industry, recognized for his broad knowledge, skills and experience in venture capital, financial services and new business formation and development. Dr. Teixeira has an extensive consulting background in the…

Continue Reading

FridayNov 30, 2018 10:09 am

QualityStocksNewsBreaks – Plus Products Inc. (CSE: PLUS) Releases Q3 2018 Financial Results, Reports Record Revenue Growth of 617 Percent to $2.5M

Leading California edibles manufacturer Plus Products (CSE: PLUS) this morning announced its financial results for the three months ended September 30, 2018. The update provided Q3 2018 financial highlights, including: Record revenue of $2.56 million, reflecting a 617 percent increase over the three months ended September 30, 2017 and a 60 percent increase over Q2 2018; quarter-over-quarter retail sales growth of 104 percent to $8.0 million in Q3; gross margin of $0.38M (15 percent) for Q3 2018 compared to -$0.17M (-48 percent) in Q3 2017; strong cash position of $11.1 million at end of Q3, prior to closing of CAD$20…

Continue Reading

FridayNov 30, 2018 10:04 am

QualityStocksNewsBreaks – SinglePoint, Inc. (SING) CEO Discusses Premium CBD Product Line on MoneyTV with Donald Baillargeon

Technology and investment company SinglePoint, Inc. (OTCQB: SING) was featured on this week’s episode of MoneyTV with Donald Baillargeon. The program is internationally-syndicated with money-focused topics, featuring in-depth interviews with CEOs and executives from various companies offering insights into their operations and future outlooks. SinglePoint CEO Greg Lambrecht was featured on this week’s program to discuss the company’s launch of a premium CBD product line to its Singleseed.com website. The television program is available for immediate online viewing at www.MoneyTV.net To view the full press release, visit http://ibn.fm/rcwEl About SinglePoint, Inc. SinglePoint, Inc. is a technology and investment company with…

Continue Reading

FridayNov 30, 2018 9:23 am

QualityStocksNewsBreaks – Sharing Services, Inc. (SHRV) Subsidiary Expands into Lucrative Canadian Market

Sharing Services (OTCQB: SHRV) recently announced that in December 2018, its wholly-owned Elevacity Global subsidiary will be launching its line of nutraceutical products in the provinces of Ontario and British Columbia, Canada. In response to the international demand for its products, the company is presently in anticipation of approvals for enrollment opportunities in all other Canadian provinces. “We have placed a concentrated effort to complete the regulatory process in Canada over the past several months and are excited to start processing orders and quickly fulfill consumer demand in those provinces. We appreciate everyone’s patience while we continue to take the…

Continue Reading

ThursdayNov 29, 2018 12:05 pm

QualityStocksNewsBreaks – Medical Cannabis Payment Solutions’ (REFG) Proprietary Payment System Promotes Security

Medical Cannabis Payment Solutions (OTC: REFG) is serving the legal cannabis industry with its proprietary, FinCEN (Financial Crimes Enforcement Network) compliant, end-to-end payment processing solution. By providing an alternative to operating strictly in cash, the system encourages security by enabling business to go cashless. A recent article discussing the company reads, “The company provides payment and management solutions that are integrable for medical and recreational dispensaries and businesses  (http://ibn.fm/Wd6rI). Essentially, as a first-tier merchant processing cannabis industry pioneer, Medical Cannabis Payment Solutions offers one of the first and only wide-ranging card processing operations of its type. This is primarily to…

Continue Reading

ThursdayNov 29, 2018 11:10 am

QualityStocksNewsBreaks – Why Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) is “One to Watch”

Sproutly Canada (OTC: SRUTF) (CSE: SPR) (FRA: 38G) is engaged in developing and bringing to market cannabis consumer products with a focus on beverages. A recent article discussing the company reads, “Sproutly’s business model is focused on processing rather than cultivating, which means its success is not constrained to growing its own cannabis. The company does own a Toronto-based, ACMPR-licensed facility designed and built with a focus on cultivating pharmaceutical-grade cannabis to produce and formulate the first natural, truly water-soluble cannabis solution. Its water-soluble ingredients and bio-natural oils will deliver revolutionary brands to international markets that are searching for well-defined…

Continue Reading

ThursdayNov 29, 2018 10:55 am

QualityStocksNewsBreaks – The Flowr Corporation (TSX.V: FLWR) Releases Results for the Third Quarter and Nine Months Ended September 30, 2018

Canadian Licensed Producer of premium cannabis products The Flowr Corporation (TSX.V: FLWR) has announced its results for the third quarter and nine months ended September 30, 2018. The update provided business highlights, with financials reported in Canadian dollars, including: Completion of almost $65 million in fundraising throughout 2017 and 2018; culminating in a nearly $36 million raise as part of the reverse takeover transaction leading to FLWR’s listing on the TSX Venture Exchange; Kelowna, BC facility cultivation and harvesting a total of 358,768 grams; Health Canada sales license and entry into supply agreements with provincial authorities from British Columbia, Nova…

Continue Reading

ThursdayNov 29, 2018 10:40 am

QualityStocksNewsBreaks – CytoDyn Inc.’s (CYDY) PCaTest Clinical Study Results Demonstrate Added Value to Gleason Score, Further Support FDA filing

Biotechnology company CytoDyn (OTCQB: CYDY) today announced recent clinical study results showing that its PCaTest provides substantial additive value for predicting outcomes for prostate cancer patients compared to the Gleason score, the current standard for prostate cancer diagnosis. The new findings support CYDY’s strategy for seeking FDA approval for the PCaTest. “Unfortunately, current tests not able to precisely determine whether an individual’s cancer will result in death if not treated aggressively,” CytoDyn Chief Medical Officer and developer of the PCaTest Richard Pestell , M.D., Ph.D., F.A.C.P., M.B.A., stated in the news release. “On the other hand, aggressive treatment for prostate…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered